GPC1 and cancer: Furthermore, highly accurate quantification of GPC1 mRNA with low copy numbers in serum EVs from pancreatic cancer patients achieved by LPHN–CHDC biochips highlights their clinical potential in early cancer diagnosis and therapeutic monitoring.